SKI Market

A+| A| A-|

Indian Indices

Sensex

76,847.57 -702.68
( -0.91%)

Global Indices

Nasdaq

48,558.84 319.59
(0.66%)

Dow Jones

6,987.77 80.53
(1.17%)

Hang Seng

57,815.15 1,312.38
(2.32%)

Nikkei 225

10,601.00 18.04
(0.17%)

Forex

USD-INR

93.15 0.65
(0.70%)

EUR-INR

109.13 1.08
(1.00%)

GBP-INR

125.28 1.20
(0.96%)

JPY-INR

0.58 0.00
(0.42%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5510998

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

22.22

103096.83

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.65

Back

a b infrabuild ltd

Enbee Trade & Finance standalone net profit rises 307.32% in the December 2025 quarter

Feb 11,2026

Net profit of Enbee Trade & Finance rose 307.32% to Rs 3.34 crore in the quarter ended December 2025 as against Rs 0.82 crore during the previous quarter ended December 2024. Sales rose 67.30% to Rs 7.88 crore in the quarter ended December 2025 as against Rs 4.71 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	7.88	4.71	67
OPM %	77.28	77.71	-
PBDT	4.56	2.55	79
PBT	4.48	2.41	86
NP	3.34	0.82	307

76,847.57 -702.68 ( -0.91%)

48,558.84 319.59 (0.66%)

6,987.77 80.53 (1.17%)

57,815.15 1,312.38 (2.32%)

10,601.00 18.04 (0.17%)

93.15 0.65 (0.70%)

109.13 1.08 (1.00%)

125.28 1.20 (0.96%)

0.58 0.00 (0.42%)